June 29, 2026 · Form 4 insider transaction
GILLIS EDWARD M bought 39,521 shares of BioCardia, Inc. at $1.20 per share, a transaction worth $47.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026.